Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$3.51 USD
+0.10 (2.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.52 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Cash flow Statements
Fiscal Year End for Prime Medicine, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -198.13 | -121.82 | -165.37 | -3.41 | NA |
Depreciation/Amortization & Depletion | 1.25 | 1.97 | 1.28 | 0.04 | NA |
Net Change from Assets/Liabilities | 2.65 | -35.40 | 31.18 | 0.16 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 28.83 | 23.42 | 98.83 | -2.34 | NA |
Net Cash From Operating Activities | -165.41 | -131.83 | -34.08 | -5.54 | NA |
Property & Equipment | -8.72 | -16.10 | -4.15 | -0.64 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 27.61 | -30.34 | -68.98 | 0.00 | NA |
Other Investing Activities | -0.17 | -0.67 | -0.50 | -0.42 | NA |
Net Cash from Investing Activities | 18.71 | -47.10 | -73.63 | -1.06 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.66 | 185.54 | 270.36 | 34.95 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | 0.00 | -4.04 | -1.09 | -0.02 | NA |
Net Cash from Financing Activities | 0.66 | 181.49 | 269.28 | 34.93 | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Change In Cash & Equivalents | -146.05 | 2.57 | 161.57 | 28.33 | NA |
Cash at Beginning of Period | 201.12 | 198.55 | 36.98 | 8.65 | NA |
Cash at End of Period | 55.07 | 201.12 | 198.55 | 36.98 | NA |
Diluted Net EPS | -2.18 | -4.19 | NA | NA | NA |
Fiscal Year End for Prime Medicine, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -101.09 | -45.76 | -198.13 | -132.49 | -81.78 |
Depreciation/Amortization & Depletion | 0.77 | 0.64 | 1.25 | 1.09 | 0.77 |
Net Change from Assets/Liabilities | -34.86 | -30.11 | 2.65 | -11.80 | -14.20 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 21.98 | 7.53 | 28.83 | 21.66 | 12.84 |
Net Cash From Operating Activities | -113.20 | -67.71 | -165.41 | -121.55 | -82.38 |
Property & Equipment | -4.23 | -2.32 | -8.72 | -6.88 | -3.98 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -25.91 | -34.71 | 27.61 | -15.52 | 19.34 |
Other Investing Activities | 0.00 | 0.00 | -0.17 | -0.17 | -0.17 |
Net Cash from Investing Activities | -30.14 | -37.03 | 18.71 | -22.57 | 15.20 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 151.36 | 151.33 | 0.66 | 0.46 | 0.14 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 6.00 | 6.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 157.36 | 157.33 | 0.66 | 0.46 | 0.14 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 14.03 | 52.59 | -146.05 | -143.66 | -67.04 |
Cash at Beginning of Period | 55.07 | 55.07 | 201.12 | 201.12 | 201.12 |
Cash at End of Period | 69.10 | 107.66 | 55.07 | 57.46 | 134.07 |
Diluted Net EPS | -0.46 | -0.44 | -0.72 | -0.55 | -0.47 |